Blue Horseshoe Stocks

Blue Horseshoe Stocks: Reviewing IMMU, EBIO & More

Immunomedics, Inc. IMMU

We began tracking IMMU last month, mentioning it for the first time on May 13th, and then again in a followup on the 20th. Our timeliness in bringing what was already a steady climber to the table, as you can plainly see on the chart below.

It’s been a solid few weeks for the stock since that time. It has risen from our observed low of 3.59 to a new high of 5.44 yesterday, marking a solid 52% PPS increase in just a short time. We can also see that the volume has been steadily creeping up as well.

The last time the stock was this overbought, we saw a leveling out but not much of a consolidation. We’ll look for a similar phenomenon to occur from this point forward, and for IMMU to ultimately continue its general uptrend until we see evidence to the contrary.

Eleven Biotherapeutics, Inc. EBIO

Speaking of plays we called last month that have enjoyed extended moves up, we’ve also got on update on EBIO this morning. We tagged this stock for observation in the first week of May, and would catch it trading at a low of .80.

From there it’s been a fairly steady climb, and yesterday it too shot to new highs. As of yesterday’s top mark of 2.10, we’d witnessed a one-month rise of 163% as the stock temporarily cracked through the 200DMA. We’ll look for it to hold support at or above previous resistance in the 1.70 area on any pullbacks.

Fresh Options Idea

For a closing idea on this short week, we’ve taken notice of the chart on iShares Silver Trust SLV. It’s gapping up moderately in the premarket this morning after recently bouncing off of its lowest price in a couple of months.

Accordingly, today we’re going to look to possibly take advantage of the activity in the SLV $15-16 Weekly Calls* for intraday flip opportunities.
___

*Caution: As always, heed our caution with regard to trading options contracts with a weekly expiration on Friday. It’s something only to be attempted by advanced traders!

Extended Watchlist:
GDSI, SNST, SIGA SAND, AUY, USLV

Blue Horseshoe Stocks: HERO, Options Update & More

Hercules Offshore, Inc. HERO

We had HERO figured for a bottom-watch play, and began mentioning the stock a couple of weeks ago for the first time since last summer. After seeing a significant gap-down to start the week, the stock has responded by posting a couple green candles on the chart.

HERO is trending off of a multiple bottom, and is now going to be on our list as a potential momentum play. From the included chart below you can plainly see the kind of volatile swings the stock is capable of making. We’ll be on the lookout for it to first fill in that gap, followed by a breach of the 200DMA. Should that occur, we could see another series of gains resembling those from February and March.

Computer Sciences Corp. CSC – Options Update

Next we want to update our readers on an extended-term options idea we submitted last Wednesday. Despite already seeing significant intraweek moves from contracts within our highlighted range of CSC 06/17 $44-48 Calls, yesterday brought along further opportunities. The gains perhaps weren’t of the magnitude that we’re accustomed to seeing in many of our options plays, but they were solid chances for profits nonetheless:

$45 Calls – Range: 3.20-4.20 – Max Gain: 31%
$47 Calls – Range: 1.65-2.80 – Max Gain: 70%
$48 Calls – Range: 1.25-2.20 – Max Gain: 76%

CafePress, Inc. PRSS

Lastly, another quick idea to add to the mix in PRSS. Aside from the chart being technically attractive, trading near relative lows at a double-bottom, we’re also interested in PRSS for the Form-4 that was filed last week showing a major investor picking up a sizable chunk to add to his position (>>View Filing). We’re going to add this to our own working watchlist and observe it closely in sessions to come.

Extended Watchlist:
TDCP, AJBI, GTHP, GOVX, IMUC

Blue Horseshoe Stocks: Recap of NHMD & More

Nate’s Food Co. NHMD

First up today is a recap of NHMD, a stock that we’ve been continuously tracking since February, and one that has brought us multiple chances to profit. We revisited it in March after witnessing a consolidation to our observed low of .0012. It has since rocketed to new highs, breaking through its 200DMA and running to .014 yesterday. That marked an impressive run of 1066% over a span of less than two months!

We’ll be anxious to observe to followup activity to that huge spike. Ideally, we’ll see NHMD hold support at or above its 200DMA of .0115 on any pullbacks.

Cliffs Natural Resources, Inc. CLF

CLF was included in yesterday’s report after noticing a number of bullish indicators forming on the chart. It’s going to remain on our radar after the stock responded with a subdued but respectable performance on the day, as well as gapping up further in the premarket today.

So far we’ve only seen a 12% rise from this play, but will still be observing closely moving forward as it just cracked the 50DMA in a bullish manner, in addition to recently receiving an analyst upgrade as well as exhibiting significantly heightened volume.

New York & Company, Inc. NWY – Update

We wanted to take a minute this morning to update our readers on a recent bottom-watch call we made, and reiterate our interest in tracking its activity over an extended term.

We called attention to NWY in our premarket report from a week ago today, and while it has yet to really blast off, our timing in pointing out the bottom was about as good as it could have been. It has managed to establish higher lows in each of the four sessions since then, despite only seeing a marginal trading range of 11%

The stock remains heavily oversold, and as such will continue to have a slot of our watchlist moving forward on the chance that a more significant rebound is in the cards.

Extended Watchlist:
BOSC, IMNP, OPGN, APHD, PACD, VMEM

Blue Horseshoe Stocks: CPXX Buyout & More

Celator Pharmaceuticals, Inc. CPXX

Just under a couple of weeks ago, we chose to alert CPXX in our morning report from May 19th. The stock had been gaining significant ground in sessions prior to that, to the point we felt it warranted our attention.

It was a good thing we drew attention to it when we did, because what followed was a solid run-up from our observed low of 15.73 into the $18-range. This morning, our witnessed gains received yet another big boost, as a takeover has been announced that will see CPXX acquired by Jazz Pharmaceuticals for $1.5B, or, 30.25 a share.

As of this morning’s premarket high on CPXX, our observed PPS increase on the stock in a matter of just seven trading sessions has been extended to a very solid 95%

Jazz Pharmaceuticals And Celator Pharmaceuticals Announce Agreement For Jazz Pharmaceuticals To Acquire Celator For $30.25 Per Share (Tue 3:30AM EDT)

Lending Club Corp. LC

Speaking of extended gains from plays that we’ve been discussing recently, we also had LC put up a noteworthy performance on Friday that culminated in new highs for us since we began tracking the stock.

Just to refresh our readers’ memories, we called LC as a bottom-bounce candidate last Monday, at which time we observed a low of 4.19. Friday’s run carried it to a high of 5.10, marking an intraweek move of 22%

We’re going to want to continue to monitor its progress as the chart is still looking quite ripe for a continued uptrend. As you can see on the provided chart snapshot, we’ve got a steadily-strengthening RSI combined with a recent bullish MACD cross in addition to a significant gap on the chart that runs from the 5.50’s to the 6.70’s.

Cliffs Natural Resources, Inc. CLF

We’re also going to place a tag on CLF this morning. We like the recent activity and the look of the current chart. Like the aforementioned play, we’re faced with a number of bullish indicators that are urging us to keep CLF on our radars as we kick off a new trading week.

Extended Watchlist:
CATS, NHMD, SQI, GEVO, NERV, FRO

Blue Horseshoe Stocks: Options Roundup

Dollar Tree, Inc. DLTR – Options Update

Yesterday, apart from highlighting the many winning options plays that came out of Wednesday morning’s premarket report, we also brought up a new idea for the DLTR options chain. We signaled the DLTR Weekly $85 Calls.

Those $85 Calls were big movers, trading in a range from 1.90-4.66 on the day. That represented an intraday pop of 145% so cheers to any of those who may have taken advantage of that healthy run.

Big Lots, Inc. BIG

We’re looking to BIG this morning on the heels of an earnings beat and cash dividend annoucment. The stock is gapping considerably above the $50-level to new annual highs. We’re going to be looking at the BIG Weekly $47.50-52.50 Calls* for possible quick-hit trades today.

*Caution: We always like to remind our readers that trading options contracts with a weekly expiration on Friday is an inherently risky proposition. Please do not attempt to do so if you are not an advanced-level trader.

Relypsa, Inc. RLYP

We’re coming across RLYP at an interesting time today. The stock is gapping up this morning, oddly enough, on news that hit for a rival.The FDA refused approval to pharma giant AstraZeneca for its potassium-lowering drug, effectively leaving RLYP’s competing drug as the lone option in the marketplace.

We’ve formulated an options idea for this play as well. With no weeklies available, we’re going to be monitoring contracts within the range of the RLYP 06/03 $20-25 Calls.

Extended Watchlist:
NNRX, KGNX, NEIK, TBEV